Lung cancer claims more lives than any other cancer in the world and remains difficult to diagnose in the early stages. This article examines the current state of lung cancer detection and screening via low-dose computed tomography (LDCT) in Alaska and considers potential opportunities for occupational therapy practitioners in primary care settings. Medicare requires at least one documented shared decision-making encounter between provider and patient before LDCT lung cancer screening occurs. As a result of time constraints, documentation requirements, and the plethora of preventive health services they provide, primary care physicians often lack the time and training to conduct this essential service. This provides an opportunity for occupational therapy practitioners to perform these services as part of their practice and to play a role in this area as patient educators and prevention specialists in primary care settings.What This Article Adds: This article explores the national health crisis of lung cancer and describes how occupational therapists can participate in providing care in primary care settings.L ung cancer claims more lives than any other cancer in the world. In 2018, an estimated 142,670 people in the United States died from lung cancer, with an estimated 228,150 new lung cancer diagnoses (Centers for Medicare & Medicaid Services [CMS], 2020). The incidence of lung cancer is predicted to increase in developed countries, especially among women; lung cancer now claims more lives than breast cancer (Martín-Sańchez et al., 2018).Late diagnosis of lung cancer is a global concern that transcends disciplines and health care systems. Late diagnoses are attributed to many causes, such as late presentation by the patient to providers, imprecise screening tools, lack of provider knowledge about lung cancer, and gaps in health care systems with respect to referrals and follow-up care (Singh et al., 2010(Singh et al., , 2012Wagland et al., 2017). The current literature highlights a need for research from a variety of perspectives and professions to fully address the issue (Salomaa et al., 2005;Singh et al., 2007). To promote early detection of lung cancer and decrease mortality, global experts recommend more research and policies targeting early detection and diagnostic methods, including the multidimensional factors associated with lung cancer detection (Andreano et al., 2018;Wong, 2018). Late diagnosis is especially disheartening for lung cancer researchers because survival rates for people diagnosed with Stage III or IV lung cancer have increased only modestly in the past 40 yr (Johnson et al., 2014). More research, especially in geographic areas that lack access to health care, is necessary to understand the barriers to lung cancer detection in community settings (Rai et al., 2019).
Literature ReviewMany screening options, such as sputum cytology, chest radiography, and low-dose computed tomography (LDCT), have been trialed to diagnose lung cancer and reduce mortality. In 2013, the U.S. Preventive Services...